Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xandra Owens Breakefield, Ph.D.

Co-Author

This page shows the publications co-authored by Xandra Breakefield and Roderick Bronson.
Connection Strength

0.813
  1. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Sci Adv. 2021 Jan; 7(2).
    View in: PubMed
    Score: 0.235
  2. Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Mol Ther Methods Clin Dev. 2019 Dec 13; 15:18-26.
    View in: PubMed
    Score: 0.213
  3. Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. Neurobiol Dis. 2015 Oct; 82:22-31.
    View in: PubMed
    Score: 0.159
  4. Stochastic model of Tsc1 lesions in mouse brain. PLoS One. 2013; 8(5):e64224.
    View in: PubMed
    Score: 0.138
  5. Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2. Neoplasia. 2002 Nov-Dec; 4(6):501-9.
    View in: PubMed
    Score: 0.067
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.